Report cover image

Global Prevent Meningitis Vaccine Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 110 Pages
SKU # APRC20353967

Description

Summary

According to APO Research, The global Prevent Meningitis Vaccine market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Prevent Meningitis Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Prevent Meningitis Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Prevent Meningitis Vaccine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Prevent Meningitis Vaccine include GSK, China National Biotec Group, Zhejiang Tianyuan, Sanofi Pasteur, Novartis, Merck, Tianjin CanSino Biotechnology, Pfizer and Hualan Bio, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prevent Meningitis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prevent Meningitis Vaccine.

The Prevent Meningitis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prevent Meningitis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Prevent Meningitis Vaccine Segment by Company

GSK
China National Biotec Group
Zhejiang Tianyuan
Sanofi Pasteur
Novartis
Merck
Tianjin CanSino Biotechnology
Pfizer
Hualan Bio
Beijing Tiantan Biological
Baxter International
Zhifei
Wyeth Pharmaceuticals, Inc
Walvax
Serum Institute of India
JN International Medical Corporation
CSL Behring
Bio-Med

Prevent Meningitis Vaccine Segment by Type

Meningococcal AC Vaccine
Meningococcal A Vaccine
Meningococcal B Vaccine (MenB)
Meningococcal Conjugate Vaccine (MenaCWY)

Prevent Meningitis Vaccine Segment by Application

Baby
Teenager
Child
Others

Prevent Meningitis Vaccine Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prevent Meningitis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prevent Meningitis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prevent Meningitis Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prevent Meningitis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Prevent Meningitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Table of Contents

110 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Prevent Meningitis Vaccine Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Prevent Meningitis Vaccine Sales Estimates and Forecasts (2020-2031)
1.3 Prevent Meningitis Vaccine Market by Type
1.3.1 Meningococcal AC Vaccine
1.3.2 Meningococcal A Vaccine
1.3.3 Meningococcal B Vaccine (MenB)
1.3.4 Meningococcal Conjugate Vaccine (MenaCWY)
1.4 Global Prevent Meningitis Vaccine Market Size by Type
1.4.1 Global Prevent Meningitis Vaccine Market Size Overview by Type (2020-2031)
1.4.2 Global Prevent Meningitis Vaccine Historic Market Size Review by Type (2020-2025)
1.4.3 Global Prevent Meningitis Vaccine Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Prevent Meningitis Vaccine Sales Breakdown by Type (2020-2025)
1.5.2 Europe Prevent Meningitis Vaccine Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Prevent Meningitis Vaccine Sales Breakdown by Type (2020-2025)
1.5.4 South America Prevent Meningitis Vaccine Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Prevent Meningitis Vaccine Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Prevent Meningitis Vaccine Industry Trends
2.2 Prevent Meningitis Vaccine Industry Drivers
2.3 Prevent Meningitis Vaccine Industry Opportunities and Challenges
2.4 Prevent Meningitis Vaccine Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Prevent Meningitis Vaccine Revenue (2020-2025)
3.2 Global Top Players by Prevent Meningitis Vaccine Sales (2020-2025)
3.3 Global Top Players by Prevent Meningitis Vaccine Price (2020-2025)
3.4 Global Prevent Meningitis Vaccine Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Prevent Meningitis Vaccine Major Company Production Sites & Headquarters
3.6 Global Prevent Meningitis Vaccine Company, Product Type & Application
3.7 Global Prevent Meningitis Vaccine Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Prevent Meningitis Vaccine Market CR5 and HHI
3.8.2 Global Top 5 and 10 Prevent Meningitis Vaccine Players Market Share by Revenue in 2024
3.8.3 2023 Prevent Meningitis Vaccine Tier 1, Tier 2, and Tier 3
4 Prevent Meningitis Vaccine Regional Status and Outlook
4.1 Global Prevent Meningitis Vaccine Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Prevent Meningitis Vaccine Historic Market Size by Region
4.2.1 Global Prevent Meningitis Vaccine Sales in Volume by Region (2020-2025)
4.2.2 Global Prevent Meningitis Vaccine Sales in Value by Region (2020-2025)
4.2.3 Global Prevent Meningitis Vaccine Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Prevent Meningitis Vaccine Forecasted Market Size by Region
4.3.1 Global Prevent Meningitis Vaccine Sales in Volume by Region (2026-2031)
4.3.2 Global Prevent Meningitis Vaccine Sales in Value by Region (2026-2031)
4.3.3 Global Prevent Meningitis Vaccine Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Prevent Meningitis Vaccine by Application
5.1 Prevent Meningitis Vaccine Market by Application
5.1.1 Baby
5.1.2 Teenager
5.1.3 Child
5.1.4 Others
5.2 Global Prevent Meningitis Vaccine Market Size by Application
5.2.1 Global Prevent Meningitis Vaccine Market Size Overview by Application (2020-2031)
5.2.2 Global Prevent Meningitis Vaccine Historic Market Size Review by Application (2020-2025)
5.2.3 Global Prevent Meningitis Vaccine Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Prevent Meningitis Vaccine Sales Breakdown by Application (2020-2025)
5.3.2 Europe Prevent Meningitis Vaccine Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Prevent Meningitis Vaccine Sales Breakdown by Application (2020-2025)
5.3.4 South America Prevent Meningitis Vaccine Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Prevent Meningitis Vaccine Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 GSK
6.1.1 GSK Comapny Information
6.1.2 GSK Business Overview
6.1.3 GSK Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GSK Prevent Meningitis Vaccine Product Portfolio
6.1.5 GSK Recent Developments
6.2 China National Biotec Group
6.2.1 China National Biotec Group Comapny Information
6.2.2 China National Biotec Group Business Overview
6.2.3 China National Biotec Group Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 China National Biotec Group Prevent Meningitis Vaccine Product Portfolio
6.2.5 China National Biotec Group Recent Developments
6.3 Zhejiang Tianyuan
6.3.1 Zhejiang Tianyuan Comapny Information
6.3.2 Zhejiang Tianyuan Business Overview
6.3.3 Zhejiang Tianyuan Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Zhejiang Tianyuan Prevent Meningitis Vaccine Product Portfolio
6.3.5 Zhejiang Tianyuan Recent Developments
6.4 Sanofi Pasteur
6.4.1 Sanofi Pasteur Comapny Information
6.4.2 Sanofi Pasteur Business Overview
6.4.3 Sanofi Pasteur Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sanofi Pasteur Prevent Meningitis Vaccine Product Portfolio
6.4.5 Sanofi Pasteur Recent Developments
6.5 Novartis
6.5.1 Novartis Comapny Information
6.5.2 Novartis Business Overview
6.5.3 Novartis Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis Prevent Meningitis Vaccine Product Portfolio
6.5.5 Novartis Recent Developments
6.6 Merck
6.6.1 Merck Comapny Information
6.6.2 Merck Business Overview
6.6.3 Merck Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Merck Prevent Meningitis Vaccine Product Portfolio
6.6.5 Merck Recent Developments
6.7 Tianjin CanSino Biotechnology
6.7.1 Tianjin CanSino Biotechnology Comapny Information
6.7.2 Tianjin CanSino Biotechnology Business Overview
6.7.3 Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Tianjin CanSino Biotechnology Prevent Meningitis Vaccine Product Portfolio
6.7.5 Tianjin CanSino Biotechnology Recent Developments
6.8 Pfizer
6.8.1 Pfizer Comapny Information
6.8.2 Pfizer Business Overview
6.8.3 Pfizer Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Pfizer Prevent Meningitis Vaccine Product Portfolio
6.8.5 Pfizer Recent Developments
6.9 Hualan Bio
6.9.1 Hualan Bio Comapny Information
6.9.2 Hualan Bio Business Overview
6.9.3 Hualan Bio Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hualan Bio Prevent Meningitis Vaccine Product Portfolio
6.9.5 Hualan Bio Recent Developments
6.10 Beijing Tiantan Biological
6.10.1 Beijing Tiantan Biological Comapny Information
6.10.2 Beijing Tiantan Biological Business Overview
6.10.3 Beijing Tiantan Biological Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Beijing Tiantan Biological Prevent Meningitis Vaccine Product Portfolio
6.10.5 Beijing Tiantan Biological Recent Developments
6.11 Baxter International
6.11.1 Baxter International Comapny Information
6.11.2 Baxter International Business Overview
6.11.3 Baxter International Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Baxter International Prevent Meningitis Vaccine Product Portfolio
6.11.5 Baxter International Recent Developments
6.12 Zhifei
6.12.1 Zhifei Comapny Information
6.12.2 Zhifei Business Overview
6.12.3 Zhifei Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zhifei Prevent Meningitis Vaccine Product Portfolio
6.12.5 Zhifei Recent Developments
6.13 Wyeth Pharmaceuticals, Inc
6.13.1 Wyeth Pharmaceuticals, Inc Comapny Information
6.13.2 Wyeth Pharmaceuticals, Inc Business Overview
6.13.3 Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Wyeth Pharmaceuticals, Inc Prevent Meningitis Vaccine Product Portfolio
6.13.5 Wyeth Pharmaceuticals, Inc Recent Developments
6.14 Walvax
6.14.1 Walvax Comapny Information
6.14.2 Walvax Business Overview
6.14.3 Walvax Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Walvax Prevent Meningitis Vaccine Product Portfolio
6.14.5 Walvax Recent Developments
6.15 Serum Institute of India
6.15.1 Serum Institute of India Comapny Information
6.15.2 Serum Institute of India Business Overview
6.15.3 Serum Institute of India Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Serum Institute of India Prevent Meningitis Vaccine Product Portfolio
6.15.5 Serum Institute of India Recent Developments
6.16 JN International Medical Corporation
6.16.1 JN International Medical Corporation Comapny Information
6.16.2 JN International Medical Corporation Business Overview
6.16.3 JN International Medical Corporation Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.16.4 JN International Medical Corporation Prevent Meningitis Vaccine Product Portfolio
6.16.5 JN International Medical Corporation Recent Developments
6.17 CSL Behring
6.17.1 CSL Behring Comapny Information
6.17.2 CSL Behring Business Overview
6.17.3 CSL Behring Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.17.4 CSL Behring Prevent Meningitis Vaccine Product Portfolio
6.17.5 CSL Behring Recent Developments
6.18 Bio-Med
6.18.1 Bio-Med Comapny Information
6.18.2 Bio-Med Business Overview
6.18.3 Bio-Med Prevent Meningitis Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Bio-Med Prevent Meningitis Vaccine Product Portfolio
6.18.5 Bio-Med Recent Developments
7 North America by Country
7.1 North America Prevent Meningitis Vaccine Sales by Country
7.1.1 North America Prevent Meningitis Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Prevent Meningitis Vaccine Sales by Country (2020-2025)
7.1.3 North America Prevent Meningitis Vaccine Sales Forecast by Country (2026-2031)
7.2 North America Prevent Meningitis Vaccine Market Size by Country
7.2.1 North America Prevent Meningitis Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Prevent Meningitis Vaccine Market Size by Country (2020-2025)
7.2.3 North America Prevent Meningitis Vaccine Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Prevent Meningitis Vaccine Sales by Country
8.1.1 Europe Prevent Meningitis Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Prevent Meningitis Vaccine Sales by Country (2020-2025)
8.1.3 Europe Prevent Meningitis Vaccine Sales Forecast by Country (2026-2031)
8.2 Europe Prevent Meningitis Vaccine Market Size by Country
8.2.1 Europe Prevent Meningitis Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Prevent Meningitis Vaccine Market Size by Country (2020-2025)
8.2.3 Europe Prevent Meningitis Vaccine Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Prevent Meningitis Vaccine Sales by Country
9.1.1 Asia-Pacific Prevent Meningitis Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Prevent Meningitis Vaccine Sales by Country (2020-2025)
9.1.3 Asia-Pacific Prevent Meningitis Vaccine Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Prevent Meningitis Vaccine Market Size by Country
9.2.1 Asia-Pacific Prevent Meningitis Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Prevent Meningitis Vaccine Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Prevent Meningitis Vaccine Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Prevent Meningitis Vaccine Sales by Country
10.1.1 South America Prevent Meningitis Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Prevent Meningitis Vaccine Sales by Country (2020-2025)
10.1.3 South America Prevent Meningitis Vaccine Sales Forecast by Country (2026-2031)
10.2 South America Prevent Meningitis Vaccine Market Size by Country
10.2.1 South America Prevent Meningitis Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Prevent Meningitis Vaccine Market Size by Country (2020-2025)
10.2.3 South America Prevent Meningitis Vaccine Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Prevent Meningitis Vaccine Sales by Country
11.1.1 Middle East and Africa Prevent Meningitis Vaccine Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Prevent Meningitis Vaccine Sales by Country (2020-2025)
11.1.3 Middle East and Africa Prevent Meningitis Vaccine Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Prevent Meningitis Vaccine Market Size by Country
11.2.1 Middle East and Africa Prevent Meningitis Vaccine Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Prevent Meningitis Vaccine Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Prevent Meningitis Vaccine Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Prevent Meningitis Vaccine Value Chain Analysis
12.1.1 Prevent Meningitis Vaccine Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Prevent Meningitis Vaccine Production Mode & Process
12.2 Prevent Meningitis Vaccine Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Prevent Meningitis Vaccine Distributors
12.2.3 Prevent Meningitis Vaccine Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.